Introduction: We aimed to demonstrate if fosfomycin tromethamine (FT) treatment could be the treatment of choice in ESBL-producing Enterobacteriaceae strains as an alternative to carbapenem particularly in patients who we would like to treat on an outpatient basis.
Methodology: We retrospectively analyzed the medical records of all patients who admitted to infectious disease outpatient clinic with complaints of dysuria and frequency and received FT for lower UTI between May 2016 and May 2017.
Results: A total of 48 patients, 19 females (39.
We evaluated the epidemiological features and main risk factors of Crimean-Congo haemorrhagic fever (CCHF) in Corum, where the disease is endemic, by retrospectively analysing the medical records of all patients diagnosed with CCHF over five years. Diagnosis was made by the detection of virus RNA via reverse transcription polymerase chain reaction or by demonstrating IgM antibody of CCHF virus with an ELISA blood test. Of 399 patients, 22 (5.
View Article and Find Full Text PDF